One of China’s biggest global technology and e-commerce leaders, Alibaba Group, has agreed to a $600 million settlement to resolve a long-running legal dispute with the U.S. government centered on allegations that the company facilitated the import and sale of illegal pharmaceuticals, controlled substances, regulated chemicals, and unapproved pill manufacturing equipment into the United States.
Alibaba runs two of the world’s largest cross-border e-commerce platforms, Alibaba.com and AliExpress.com, which connect thousands of third-party merchants based around the globe to U.S. consumers. According to U.S. law enforcement allegations, Alibaba’s U.S.-based payment processing arm, AUS Merchant Services, violated federal requirements by failing to put in place sufficient safeguards to block unauthorized merchants from moving unlawful goods into the U.S. through the company’s two major platforms.
As part of the non-prosecution agreement reached with the U.S. Department of Justice, Alibaba formally acknowledged that between January 2016 and December 2024, it failed to halt approximately 80,000 illegal product transactions that violated the Federal Food, Drug, and Cosmetic Act and multiple other federal statutes. Official documents from the settlement also confirm that internal Alibaba employees had previously flagged gaps in the company’s compliance systems that left the platforms vulnerable to illegal trade. In a number of cases, bad actors even used Alibaba’s built-in messaging tool to redirect buyers to external third-party messaging platforms, where they could complete illicit transactions away from Alibaba’s official monitoring systems.
The investigation into Alibaba’s practices involved coordinated law enforcement action across multiple federal agencies, including the U.S. Food and Drug Administration, the Federal Deposit Insurance Corporation, and IRS Criminal Investigation. As part of the probe, agents carried out more than 40 undercover purchases that confirmed the presence of the restricted, illegal goods for sale on Alibaba’s platforms. Instead of pursuing criminal prosecution, the Justice Department negotiated a non-prosecution agreement alongside the $600 million settlement, a framework that requires Alibaba to implement sweeping reforms to its U.S.-focused compliance protocols.
In an official statement released after the deal was finalized, Alibaba noted that the agreement represented a mutually acceptable resolution that will help the company enforce stricter product sale rules for the third-party merchants that operate on its U.S.-facing e-commerce platforms. This settlement marks the latest high-profile regulatory clash between Alibaba and U.S. government authorities, coming after recent moves by the Pentagon to label the company a “Chinese military company” — a designation the firm has formally challenged in federal court, and one that has drawn opposition from Chinese government officials.
Jarod Koopman, chief of IRS Criminal Investigation, emphasized that the resolution sends a clear message to all global companies operating in the U.S. market. “This outcome underscores IRS Criminal Investigation’s commitment to following the money and ensuring that companies operating in the United States comply fully with federal law,” Koopman said in the official settlement announcement.